Types
- Major depressive disorder — at least two weeks of low mood or loss of interest, plus other symptoms such as sleep or appetite changes, low energy, poor concentration, or feelings of worthlessness.
- Persistent depressive disorder (dysthymia) — milder symptoms lasting two years or more.
- Perinatal depression — during pregnancy or after childbirth.
- Depression with a seasonal pattern (seasonal affective disorder).
- Bipolar depression — part of bipolar disorder, which is treated differently.
Prevention
- Staying physically active, keeping social connections, sleeping regularly, and limiting alcohol all protect mood.
- After recovery, continuing treatment for the recommended time lowers the chance of relapse.
Risk factors
- Family history, with genetic risk spread across many genes3
- Stressful life events, trauma, and loneliness
- Chronic illness and chronic pain
- Alcohol and drug use
- Pregnancy and the months after childbirth
- Ongoing sleep problems
Diagnostics
- Screening questionnaires such as the PHQ-9, often in primary care.
- Diagnosis through a clinical interview using DSM-5 criteria.
- Blood tests when needed to rule out medical causes such as thyroid disease, anemia, or low vitamin B12.
- Checking for suicide risk and for bipolar disorder before treatment starts.
- If you're thinking about suicide, call or text 988 in the US now.
Treatments
- Psychotherapy such as cognitive behavioral therapy, behavioral activation, interpersonal therapy, and problem-solving therapy2.
- Antidepressants — all 21 drugs compared in a large analysis worked better than placebo for adults with major depression1.
- Therapy plus medication works better than either alone2.
- Exercise — walking or jogging, yoga, and strength training reduced depression, with benefits comparable to psychotherapy4.
- Severe or treatment-resistant depression has specialist options, listed below.
Molecular Biomarkers
- No blood test or brain scan can diagnose depression.
- Inflammatory markers such as C-reactive protein are being studied but aren't used in care.
- Pharmacogenomic tests (for example CYP2D6 and CYP2C19) can help choose doses of some antidepressants.
Genes
- Depression is polygenic. A genome-wide meta-analysis of more than 800,000 people found 102 independent genetic variants, each with a tiny effect, many in genes active in the brain's prefrontal regions3.
- There is no single "depression gene," and genetic tests can't predict who will develop depression.
Lifestyle
- Exercise regularly; more vigorous exercise helps more4.
- Keep a regular sleep schedule.
- Limit alcohol and avoid recreational drugs.
- Stay connected with people you trust.
Nutrition
- In the SMILES trial, adults with moderate-to-severe depression who received dietitian support for a Mediterranean-style diet were more likely to reach remission than those given social support (32% vs. 8%)5.
- Diet works alongside standard treatment, not instead of it.
- Evidence for omega-3 supplements is mixed.
Medical Interventions
- Electroconvulsive therapy (ECT) — highly effective for severe, treatment-resistant, or psychotic depression
- Transcranial magnetic stimulation (TMS)
- Esketamine nasal spray for treatment-resistant depression, given in a certified clinic
- Intensive outpatient or hospital care for people at risk of harming themselves
Pharmaceutical Drugs
- SSRIs: escitalopram, sertraline, fluoxetine, citalopram, paroxetine1
- SNRIs: venlafaxine, duloxetine1
- Others: bupropion, mirtazapine, vortioxetine1
- Tricyclics: amitriptyline — effective, but with more side effects1
- Esketamine (nasal) for treatment-resistant depression, and zuranolone for postpartum depression
- Never stop an antidepressant suddenly; taper with your prescriber.
Sources
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
- Cuijpers P, Noma H, Karyotaki E, Vinkers CH, Cipriani A, Furukawa TA. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19(1):92-107. doi:10.1002/wps.20701
- Howard DM, Adams MJ, Clarke TK, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22(3):343-352. doi:10.1038/s41593-018-0326-7
- Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024;384:e075847. doi:10.1136/bmj-2023-075847
- Jacka FN, O'Neil A, Opie R, et al. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Med. 2017;15(1):23. doi:10.1186/s12916-017-0791-y
This page summarizes published research for education. It isn't medical advice and doesn't replace care from a clinician who knows your history. Never start, stop, or change a medication without talking to your prescriber.